Many polyubiquitinated proteins are extracted from membranes or complexes by the conserved ATPase Cdc48 (in yeast; p97 or VCP in mammals) before proteasomal degradation. Each Cdc48 hexamer contains two stacked ATPase rings (D1 and D2) and six N-terminal (N) domains. Cdc48 binds various cofactors, including the Ufd1-Npl4 heterodimer. Here, we report structures of the Cdc48-Ufd1-Npl4 complex from Chaetomium thermophilum. Npl4 interacts through its UBX-like domain with a Cdc48 N domain, and it uses two Zn 2+ -finger domains to anchor the enzymatically inactive Mpr1-Pad1 N-terminal (MPN) domain, homologous to domains found in several isopeptidases, to the top of the D1 ATPase ring. The MPN domain of Npl4 is located above Cdc48's central pore, a position similar to the MPN domain from deubiquitinase Rpn11 in the proteasome. Our results indicate that Npl4 is unique among Cdc48 cofactors and suggest a mechanism for binding and translocation of polyubiquitinated substrates into the ATPase.
C ertain polyubiquitinated substrates cannot be directly degraded by the proteasome because they are well folded or located in membranes, chromatin, or multimeric complexes. These proteins are generally extracted from such assemblies and unfolded by a conserved ATPase, called Cdc48 in yeast and p97 or VCP in mammals (denoted Cdc48/p97 hereafter), before being transferred to the proteasome 1 . Cdc48/p97 belongs to the AAA family of ATPases. The Cdc48/p97 hexamer contains two ATPase rings (D1 and D2) and N-terminal (N) domains that can be captured in different conformations 2 . Upon ATP binding by the D1 ATPases, the N domains transition from a 'down conformation' coplanar with the D1 ring to an 'up conformation' above the D1 plane 3, 4 . Structural studies also indicate that the D1 and D2 ATPase rings undergo relative rotations upon ATP binding by D2 (ref. 4 ).
Cdc48/p97 binds various cofactors, which determine substrate specificity, target the ATPase to different cellular locations, or modify the ubiquitin chain attached to the substrate 5 . The precise functions of these cofactors are poorly understood. All known cofactors bind either the N domain of Cdc48/p97 or its unstructured C-terminal tail 5 . The Ufd1-Npl4 heterodimer (UN) 6 is one of the most important cofactors; it participates in many Cdc48-dependent processes, including endoplasmic reticulum-associated protein degradation, a process in which misfolded proteins are extracted from the endoplasmic reticulum membrane and degraded by the proteasome 7 . Like Cdc48, both Ufd1 and Npl4 are evolutionarily conserved and essential for cell viability. Npl4 is a target of the potential cancer drug disulfiram 8 .
Npl4 contains an N-terminal UBX-like domain that binds the N domain of Cdc48 and is predicted to have a Zn 2+ finger (zf-Npl4) followed by an MPN domain 9 (Fig. 1a ). MPN domains are found in several Zn 2+ -dependent isopeptidases, including AMSH and AMSH-LP, the COP9 signalosome subunit CSN5, and the proteasomal deubiquitinase (DUB) Rpn11 (refs. [10] [11] [12] . Apart from the zf-Npl4 domain, mammalian Npl4 contains a C-terminal Zn 2+ -finger domain that binds ubiquitin, but this domain is absent in yeast orthologs 13 . Ufd1 has two short SHP motifs that bind Cdc48, and a ubiquitin-binding UT3 domain with homology to the N domain of Cdc48 (ref. 14 ) . Ufd1 interacts with Npl4 through its UT6 domain, a segment predicted to be unstructured 15 (Fig. 1a ). Cdc48 and Npl4 can also interact with Vms1, instead of Ufd1, and Vms1 then recruits the ATPase complex to mitochondria 16 .
Recent in vitro experiments with purified Cdc48, UN cofactor, and a polyubiquitinated model substrate have yielded some mechanistic insight 17 . After interaction of the polyubiquitin chain with UN, Cdc48 uses ATP hydrolysis in the D2 domain to move and unfold the polypeptide substrate through its central pore. ATP hydrolysis in the D1 domain is involved in substrate release from Cdc48, a process that requires the cooperation of the ATPase with a DUB. The DUB trims the polyubiquitin chain, and the remaining oligoubiquitin chain is then also translocated through the pore. These experiments have indicated that at least two strands of the translocating polypeptide chain can be present in the central pore, as has also been found for other hexameric AAA ATPases 18, 19 .
The mechanism by which translocation of a polypeptide chain through Cdc48 is initiated is unclear. One unresolved issue is how the polyubiquitin chain is recognized by the UN complex. The only well-characterized ubiquitin-binding site is in the UT3 domain of Ufd1 (ref. 20 ). How a polypeptide chain is moved into the central pore of Cdc48 is even less understood. A substrate segment must move through the D1 ring before the D2 ATPases can use their loop residues to grab the polypeptide and pull it through the pore 17, 21 . This requirement is particularly puzzling, because Cdc48 can act on a large variety of folded substrates. In contrast, initiation of translocation by the ATPase ring of the 19S subunit of the proteasome is much easier to understand. Here, the substrate needs a flexible polypeptide segment that inserts into the pore of the single ATPase ring and serves as the initiation site 22 .
Structure of the Cdc48 ATPase with its ubiquitinbinding cofactor Ufd1-Npl4
(Supplementary Figs. 2, 3 and 5a). Some classes in ATP-γ S were in the down conformation, perhaps because of slow nucleotide hydrolysis. The conformational switch of the N domains is probably triggered by the change in the nucleotide state of the D1 ring 3 . The thermophilic Cdc48 protein thus recapitulates essential features of the mammalian p97 ATPase.
Next, we purified a complex of Cdc48 and UN. The UN complex from C. thermophilum was again expressed in E. coli and had the expected 1:1 stoichiometry after purification ( Supplementary  Fig. 1c ). A complex of hexameric Cdc48 and UN ( Supplementary  Fig. 1d ) was subjected to single-particle cryo-EM analysis in the presence of ADP or ATP-γ S ( Table 1 and Supplementary Figs. 4-7) . The refined structures had overall resolutions of 6.7 Å and 4.3 Å with ADP and ATP-γ S, respectively. The presence of the cofactor had only a small effect on the structure of the ATPase rings (Supplementary Figs. 5-7). However, even in the ADP-bound state, a sizable population of the Cdc48 molecules had their N domain in the up conformation, although the percentage was lower than that in the ATP-γ S-bound state (~60% versus ~95%; Supplementary Figs. 6 and 7). Thus, ATP and cofactor binding together move the N domains into the up conformation, a state probably required for initiation of substrate processing 17 .
The most obvious density contributed by the cofactor complex is a central tower that lies above the D1 ATPase ring (Fig. 1b) . In addition, some 3D classes show density close to one of the N domains, a result that can be attributed to the UBX-like domain of Npl4. This domain is known to bind a hydrophobic cleft on the N domain of Cdc48, and a previously determined structure of Npl4 UBXL -p97 N fits well into this region of our cryo-EM density map 9 ( Fig. 1c and Supplementary Fig. 5c ). Deletion of the UBX-like domain abolishes binding of Npl4 to Cdc48 (ref. 25 ), thus indicating that the cofactor domains constituting the tower density interact only weakly with the ATPase despite having several contact points. The binding of the UBX-like domain to the Cdc48 N domain is probably a prerequisite for the binding of the other cofactor domains to the ATPase. Although the tower occupies a large fraction of the space above the D1 ring, the central pore remains unobstructed, thus allowing substrate to move into it ( Fig. 1b ).
Identification of Npl4 domains in the density map.
Although the density map of the Cdc48-cofactor complex permitted the visualization of helices, the resolution was insufficient to build a molecular model for the cofactor. We therefore first identified cofactor regions near the D1 ATPase ring. The Cdc48-UN complex was treated with bis[sulfosuccinimidyl] suberate (BS3), a bifunctional amine-reactive cross-linker. The sample was then digested with trypsin, and cross-linked peptides were identified by mass spectrometry. The data showed that the N terminus of Ufd1 interacts promiscuously with multiple locations in the ATPase and Npl4 ( Supplementary  Fig. 8a ), far outside the calculated dynamic range of the BS3 spacer (5.2-9.2 Å), thus suggesting that the succeeding UT3 domain is flexible. However, several lysines in the zf-Npl4 and MPN domains of Npl4 cross-linked specifically to residues on the surface of the D1 ATPase ring ( Supplementary Fig. 8a,b ). Thus, these domains were the best candidates to form the base of the central tower. In agreement with the location of the cofactor density, no cross-links were discovered between the Cdc48 D2 domain and either Ufd1 or Npl4.
Using limited proteolysis, we found that the zf-Npl4 and MPN domains form a stable fragment ( Supplementary Fig. 8c ). We determined a crystal structure of this construct by using the central tower density of the cryo-EM map as a molecular replacement (MR) model ( Table 2 ). The initial low-resolution phases derived from the EM map were extended to high resolution by using the X-ray data. Model bias was excluded by calculating a simulated annealing composite omit map ( Supplementary Fig. 9 ). The resulting crystal structure indeed fits well into the cryo-EM map ( Fig. 2a,b ), thus indicating that the Npl4 domains undergo only small changes upon Cdc48 binding. The bottom of the tower is formed by the zf-Npl4 domain, the central portion by the MPN domain, and the top portion by a C-terminal domain (CTD) of five α -helices ( Fig. 2a,b ). A small unassigned region of the central tower density probably corresponds to a segment of UT6 in Ufd1 ( Fig. 2a ). Indeed, hydrogen/ deuterium-exchange mass spectrometry experiments showed that several Npl4 peptides in this region were protected when Ufd1 was present ( Supplementary Fig. 8d,e ). The Npl4-interacting region of UT6 is likely to be located between the two SHP motifs that anchor Ufd1 to the N domains of Cdc48 (ref. 25 ). The UT3 domain of Ufd1 is not visible in the density map, thus further indicating that it is flexible. Interestingly, a domain with the same fold is also flexible in the Pex1-Pex6 ATPase, another AAA ATPase 26 . These domains might be fixed only when they bind to ubiquitinated substrate. The MPN domain of Npl4 is anchored to the top of the D1 ATPase ring of Cdc48 via the preceding Zn 2+ -finger domains, both of which are of the CHCC type, in which one histidine residue and three cysteine residues are used for coordination of the Zn 2+ ion ( Fig. 2b-d ). The Zn 2+ fingers form two 'stalks' that project into grooves between adjacent subunits of the Cdc48 D1 ring (Fig. 2b,c) . When numbered from the position of the N-terminal Zn 2+ finger, the interacting grooves are between ATPase subunits 1 and 2 and between subunits 3 and 4 ( Fig. 2c) . A third stalk is formed by segments preceding the first Zn 2+ finger as well as residues located between the two Zn 2+ fingers. This N-terminal bundle makes only a few contacts with the surface of ATPase subunit 3 and is less conserved than the Zn 2+ fingers. Finally, a fourth stalk is formed by two β -strands with a loop at their tip. This loop projects over the axial pore and faces ATPase subunit 6 ( Fig. 2c ), but it makes no clear contact with the D1 ring. The use of several contact sites precludes the binding of a second cofactor molecule ( Supplementary Fig. 9 ), thus explaining why one Cdc48 hexamer binds only one UN heterodimer.
Functional tests of Npl4 segments.
To test the functional role of the Zn 2+ fingers, we used Saccharomyces cerevisiae Cdc48, Npl4, and Ufd1 in an in vitro unfolding assay. A fusion between a short degron and the fluorescent protein mEos3.2 was polyubiquitinated and incubated with the ATPase complex; the loss of fluorescence is an indication of Eos unfolding 17 . The results showed that mutation of the central histidine and cysteine residues in either of the individual Zn 2+ -finger domains had little effect on unfolding, but a defect was observed when both domains were mutated together ( Fig. 3a) . Similarly, mutants in individual Zn 2+ fingers were able to rescue the temperature-sensitive growth phenotype of an npl4-1 yeast strain, but a mutant in both Zn 2+ fingers was not able to do so (Fig. 3b ). We also tested mutations in the Cdc48 ATPase in the unfolding assay. Both Zn 2+ -finger domains are close to a conserved triphenylalanine (FFF) sequence in the D1 domain. Indeed, mutation of the first or third phenylalanine decreased the unfolding activity of Cdc48 without affecting hexamer formation ( Fig. 3c and Supplementary Fig. 10a ). Mutation of the central phenylalanine in the FFF motif abolished unfolding completely but also decreased hexamerization, a result consistent with this residue facing a hydrophobic pocket in the ATPase domain. The importance of the Zn 2+ fingers of Npl4 is supported by a recent report in which these domains have been identified as a target of the drug disulfiram 8 . The role of the 'β -strand finger' of Npl4 remains unclear. Although there is a highly conserved tyrosine residue at the tip of the β -strand finger, its mutation or deletion did not alter unfoldase activity in vitro or affect the ability to complement the npl4-1 mutant ( Supplementary Fig. 10b ). It remains possible that a subclass of Cdc48 substrates might be dependent on the β -strand finger.
Comparison with other MPN domains. Like other members of the MPN family, the Npl4 MPN domain consists of a core MPN fold with two inserts (inserts 1 and 2) ( Fig. 4a ). Npl4 is enzymatically inactive, because it lacks the Zn 2+ -binding motif in the core, which is essential for the hydrolytic activity of other MPN domains 27 . The position of the Npl4 MPN domain above the D1 ATPase ring ( Fig. 2a-c ) is similar to that of the MPN domain in the 19S regulatory particle of the proteasome. In the case of Rpn11, an enzymatically active MPN domain is located over a ring of six homologous ATPase subunits 28 . The Rpn11 MPN domain dimerizes with the enzymatically inactive MPN domain of Rpn8. The Npl4 MPN domain, however, is a monomer, with its helical CTD occupying the site that mediates dimerization in Rpn11 (Fig. 4b) .
The MPN domains of Rpn11 and AMSH-LP accommodate the C-terminal tail of ubiquitin in a cleft between insert 1 and helix 2, thus positioning the C terminus of ubiquitin next to the active site 29, 30 (Fig. 4c ). Insert 1 of Npl4 closely resembles the structure assumed by the corresponding region of Rpn11 in the presence of ubiquitin ( Fig. 4c ), but it adopts this conformation even in the absence of ubiquitin, as has been observed for AMSH and several other MPN family members 31 . Given its similarity with Rpn11 and AMSH, the cleft in Npl4's MPN domain is also likely to accommodate the C-terminal tail of a ubiquitin molecule, but in our structure, the groove is covered by a segment of UT6 of Ufd1, thus suggesting that the UT6-MPN interaction may be broken to allow ubiquitin binding.
Ubiquitin binding by Npl4. To test whether the cleft of the MPN domain has a role in ubiquitin binding, we incubated a polyubiquitinated substrate with a streptavidin-binding peptide (SBP)-tagged version of the Npl4 construct used for crystallization. In agreement with previous results 32 , this construct indeed bound polyubiquitin, as shown after pulldown with streptavidin beads (Fig. 3d,e ). However, mutagenesis showed that the cleft of the MPN domain does not substantially contribute to the interaction. Although this result is at variance with findings from a previous report 32 , perhaps because the bait in the previous experiments was destabilized by its fusion with glutathione S-transferase, it is consistent with only a few residues in the MPN cleft of Rpn11 contacting ubiquitin 33 . Most of the affinity for ubiquitin may be provided by the interface between the MPN and CTD domains rather than by the cleft, because neither domain alone was active ( Fig. 3d ). Alternatively, both domains might have weak affinity, and the combination may be required for avid substrate recognition. Although the elucidation of the exact binding mode of polyubiquitin to the UN complex requires a structure of the Cdc48 complex with a ubiquitin chain of defined length, it is clear that the UN cofactor has ubiquitin-binding sites in both Ufd1 and Npl4, similarly to the multiple receptors present in the proteasome 34 . The core MPN region is tan, the insert 1 (Ins-1) region is magenta, the insert 2 (Ins-2) region is purple, and the CTD is orange. The dashed line indicates a nine-residue acidic loop unresolved in the crystal structure. b, As in a, but with the Rpn11-Rpn8 structure overlaid (PDB 5U4P). Rpn11 is green, and Rpn8 is gray. c, As in a, with the Rpn11 MPN (green) and its associated ubiquitin (cyan) overlaid (PDB 5U4P). The conserved tyrosine at the tip of insert 2 is shown in stick representation in red. H2, MPN helix 2; Ub, ubiquitin. 
Discussion
Our data suggest a model for the interaction of the Cdc48 ATPase with the UN cofactor ( Fig. 5a ). Npl4 interacts through its UBX-like domain with one of the N domains of the Cdc48 hexamer and uses its two Zn 2+ -finger domains to anchor its MPN domain to the top of the D1 ATPase ring. Ufd1 interacts through a short and poorly conserved segment of its UT6 domain with Npl4, and through the flanking SHP motifs with other N domains of Cdc48. The UT3 domain of Ufd1 does not appear to interact with either Npl4 or Cdc48. The interface between Npl4 and Ufd1 is surprisingly small and might even be broken when substrate binds Npl4, but Ufd1 would probably still remain bound to Cdc48 through its SHP motifs.
Our results in conjunction with those from previous studies suggest that ubiquitin molecules attached to a substrate bind both the UT3 domain of Ufd1 and the CTD and MPN domains of Npl4 (Fig. 5b) 20, 32 . These two independent interactions can explain, at least in part, why a chain length of at least five ubiquitin molecules is required to obtain maximum binding to the UN complex 17, 32 . An additional ubiquitin molecule would be located in the cleft of the MPN domain (Fig. 5b) . The cleft does not provide much affinity, but it would allow for the accommodation of the C terminus of this ubiquitin molecule in a similar manner as seen in Rpn11 of the proteasome 29 . However, in the Cdc48 complex, the putative ubiquitinbinding groove and central ATPase pore are at an approximately right angle, whereas they are more closely aligned in the proteasome 35 (Fig. 5c ). Furthermore, the catalytic site of Rpn11 is located immediately above the pore in the substrate-engaged proteasome 36 , whereas in the Cdc48-UN complex, there is an ~40 Å gap between the putative C terminus of ubiquitin and the pore (Fig. 5c ). The presence of this gap raises the question of how substrates might initially be inserted into the ATPase. One possibility is that the gap is bridged by an additional ubiquitin moiety proximal to the one bound to the MPN cleft. In this case, Cdc48 might begin translocation not on a segment of the substrate but instead on a segment of this proximal ubiquitin molecule. This model is attractive in that ubiquitin could serve as a universal initiating signal for translocation into the pore, regardless of the substrate to which it is attached. This mechanism would eliminate the need for a flexible region to mediate pore entry and explain why Cdc48, unlike the proteasome, has no requirement for a preunfolded segment. Although the details of pore insertion remain to be clarified, ideally with a structure of a substrate-associated Cdc48 complex, our data show that Npl4 is unique among the known Cdc48 cofactors in that it binds directly to the ATPase ring and probably serves as a universal gatekeeper for all Cdc48-dependent reactions that require translocation through the central pore.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41594-018-0085-x. shown: one associated with UT3, one bound at the interface between CTD and MPN, one located with its C terminus in the MPN cleft, and one in the gap between MPN and the ATPase, which might serve as an initiation site for translocation into the pore. c, Comparison between the location of the ubiquitin-bound MPN domain in the proteasome (left) with that predicted in the Cdc48 complex (right). For Rpn11, the core MPN region is tan, and the insert 1 (Ins-1) region is magenta. Ubiquitin is in cyan. For Npl4, the core MPN region is tan, the insert 1 region is magenta, the insert 2 (Ins-2) region is purple, and the CTD is orange. The approximate distance from the ubiquitin C terminus to the central-pore opening and the approximate angle between the MPN cleft and the central-pore axis are marked in red in each case. The proteasome-ubiquitin model was generated from PDB 5T0H and PDB 5U4P.
EM specimen preparation and data collection. Sample homogeneity was first examined by negative-stain EM with 0.7% (wt/vol) uranyl formate, as previously described 38 . Images were recorded with a 1,000 × 1,000 CCD camera (Gatan) on a Philips CM10 electron microscope (FEI) operated at an acceleration voltage of 100 kV and a nominal magnification of 52,000× . Before preparing grids for cryo-EM, we concentrated all samples to 2-3 mg/ml and centrifuged them at 13,000 g for 10 min to remove protein aggregates. NP-40 was added to the samples to a final concentration of 0.05% immediately before vitrification to lower the propensity of the particles to adopt preferred orientations in the ice layer.
The specimens for cryo-EM were frozen with a Cryoplunge 3 (Gatan). A 3.5-μ l aliquot of the sample was applied to a glow-discharged Quantifoil Cu 1.2/1.3 grid (Quantifoil). The grid was blotted for 2.5-3.5 s and then plunge frozen in liquid ethane, which was maintained at a temperature of -172 °C.
For analysis of Cdc48 alone, in the presence of ADP or ATP-γ S, cryo-EM data collection was carried out at Harvard Medical School, with a Polara electron microscope (FEI) operated at 300 kV and equipped with a K2 Summit direct electron detector (Gatan). All images were recorded in super-resolution counting mode with the semiautomated data-collection software UCSFImage4 (ref. 39 Image processing. For the datasets of Cdc48 alone with ADP or ATP-γ S, the image stacks were motion-corrected and binned over 2 × 2 pixels with MotionCor 41 , thus yielding a pixel size of 1.23 Å. The defocus values were estimated with CTFFIND4 (ref. 42 ). Each image was then manually inspected and rejected if considered of inadequate quality for further image processing (for example, because of ice contamination, blurriness, or poor CTF fit). Particles were manually picked from the remaining images with the e2boxer.py command in EMAN2 (ref. 43 ).
For the Cdc48 (ADP) dataset, 52,348 particles were manually picked from 1,440 images. The particles were extracted into boxes of 256 × 256 pixels in RELION 44 . A subset of these particles was used to generate 2D class averages with the iterative stable alignment and clustering (ISAC) algorithm 45 . These were then used to calculate an initial 3D map with the validation of individual parameter reproducibility (VIPER) algorithm, both implemented in SPARX 46 . With the map obtained with VIPER as reference, all particles were subjected to RELION 3D classification into five classes. One class containing 9,751 particles (~19% of the dataset) showed the most detailed structural features with apparent six-fold symmetry. This class was subjected to 3D refinement and yielded a density map at 8.9-Å resolution. When the same class was refined with C6 symmetry imposed, an improved density map at 7.2-Å resolution was obtained.
For the Cdc48 (ATP-γ S) dataset, 29,313 particles were manually picked from 354 images and extracted into boxes of 200 × 200 pixels in RELION. The particles were used to calculate 2D class averages with ISAC, and the resulting averages were used to calculate an initial 3D map with VIPER. With this map as reference, the particles were subjected to RELION 3D classification into ten classes. One class containing 3,021 particles (~10% of the dataset) showed the most well-defined structural features. This class was subjected to 3D refinement and yielded a density map at 10.3-Å resolution. Because the structure also exhibited apparent six-fold symmetry, the same class was also refined with C6 symmetry imposed, thus resulting in a map with an improved resolution of 8.2 Å.
For the Cdc48-cofactor complex in the presence of ADP or ATP-γ S, the image stacks were motion-corrected, dose-weighted, and binned over 2 × 2 pixels (thus yielding a pixel size of 1.3 Å) with MotionCor2 (ref. 47 ). The defocus values were estimated with CTFFIND4. Each image was manually inspected, and imperfect images were excluded from further processing. The remaining images were subjected to template-free particle auto-picking with Gautomatch (http://www. mrc-lmb.cam.ac.uk/kzhang/Gautomatch/).
For the Cdc48-cofactor (ADP) complex, 145,947 autopicked particles were extracted from 2,551 images into boxes of 256 × 256 pixels in RELION. These particles were subjected to reference-free 2D classification, and classes showing poor averages were removed. To obtain an initial 3D model, the remaining 141,422 particles were aligned to the Cdc48 (ADP) cryo-EM map (obtained as described above and filtered to 40 Å) with RELION 3D classification with the number of classes set to one. The resulting map showed density not present in the reference map. With this new map as a reference, the particles were sorted into six classes through 3D classification. The classes that showed strong cofactor density (classes 2, 5, and 6; 82,249 particles; ~58% of the dataset) were combined and subjected to 3D classification into ten classes. The resulting classes showed that the Cdc48-cofactor (ADP) complex also exhibits conformational variability, most notably in the N domain and the cofactor region. Classes 2, 8, 9, and 10,  showing the strongest cofactor density and relatively well-ordered N domains, were combined, and the resulting 52,178 particles were subjected to 3D refinement in RELION, thus yielding a map at 6.7-Å resolution.
For the Cdc48-cofactor (ATP-γ S) complex, the 808,059 autopicked particles were binned over 4 × 4 pixels, thus resulting in a pixel size of 5.2 Å, extracted into boxes of 64 × 64 pixels in RELION-2 (ref. 48 ), and subjected to reference-free 2D classification in RELION-2. After removal of classes giving poor averages, the remaining 616,772 particles were used as input for cryoSPARC 49 to calculate an initial 3D map. With this map as reference, the particles were sorted into eight classes through RELION-2 3D classification. Only one of the classes (containing 91,883 particles; ~15% of the dataset) showed strong density for the cofactor bound to Cdc48 and detailed structural features. Refinement of this class yielded a density map at 10.4-Å resolution. The refined particles were then reextracted from the original micrographs as recentered and unbinned particles into boxes of 256 × 256 pixels (pixel size of 1.3 Å). 3D refinement of the newly extracted particles was performed with the orientation parameters determined from the dataset of 4× -binned particles as the starting point for further optimization. The final density map had a resolution of 4.6 Å, according to the gold-standard Fourier shell correlation (FSC) curve and with the FSC = 0.143 cutoff. Because the flexibility of the N domains affects the precision of the particle alignment, the N domains were masked out for the final alignment cycles in RELION-2, thus improving the resolution of the remaining map region to 4.3 Å.
X-ray data collection and structure determination. Crystals were screened at NE-CAT beamline 24-ID-C at the Advanced Photon Source (Argonne National Laboratory). An X-ray absorption scan showing a peak at 9665.7 eV confirmed the presence of zinc, and data were accordingly collected at this energy (1.283 Å). The dataset used for structure determination (https://doi.org/10.15785/SBGRID/565) was gathered from a single crystal at 100 K. Data were processed with XDS 54 and analyzed with Aimless 55 . The crystal contained two copies per asymmetric unit. To solve the structure, we used the cryo-EM density corresponding to the cofactor central tower as an MR model according to the protocol of Jackson et al. 56 , with the programs Chimera, Phaser, RESOLVE, and the CCP4i and Phenix crystallographic suites 51, 52, [57] [58] [59] . The central tower density was converted to structure factors and placed at the origin of a P1 unit cell. This model was used to obtain an MR solution with initial low-resolution phases. We extended phases to high resolution with density modification, as implemented in RESOLVE, by taking advantage of the two-fold noncrystallographic symmetry present in the crystal. The MR solution was passed to the MR-SAD module in Phenix. Initial phases were of sufficient quality for most of the structure in the asymmetric unit to be assembled with the Autobuild function in Phenix 60 . The structure was completed through iterative rounds of manual adjustment in Coot 53 and refinement in Phenix, with TLS-parameter refinement enabled and a riding hydrogen model. Zinc fingers were refined with geometry restraints as suggested in ref. 61 . Ramachandran statistics were 96.03% favored, 3.86% allowed, and 0.11% outliers. A composite omit map with simulated annealing was generated with Phenix 59 . Figures were generated with UCSF Chimera 51 and PyMOL (http://www.pymol.org/). Crystallographic software was maintained by SBGrid 62 . Data collection and refinement statistics are summarized in Table 2 .
LC-MS/MS and cross-link mapping. Buffer components for cross-linking
were BioUltra grade (Sigma Aldrich). LC-MS/MS was carried out with Thermo Scientific LC-MS-grade reagents and solvents. The cross-linker BS3 was purchased from Thermo Scientific.
Purified protein complexes (0.5 mg/ml in 50 mM HEPES, pH 7.5, 200 mM NaCl, 5 mM MgCl 2 , 0.5 mM TCEP, and 0.1 mM ATP-γ S) were cross-linked with 100, 200, or 400 μ M of BS3 (3.5 mM stock in water) for 30 min at room temperature. The reactions were quenched by addition of Tris-HCl, pH 7.5, to a final concentration of 10 mM. Samples were dialyzed against 100 mM ammonium bicarbonate, reduced with 50 mM TCEP at 60 °C for 10 min, and alkylated with 50 mM iodoacetamide in the dark for 60 min at room temperature. Digestion was carried out at 37 °C overnight with 0.5 μ g sequencing-grade modified trypsin (Promega) in 100 mM ammonium bicarbonate. The resulting peptides were passed though C18 Spin Tips (Thermo Scientific) before elution with 40 μ l of 80% acetonitrile in 0.1% trifluoroacetic acid. Eluted peptides were dehydrated under vacuum and resuspended in 20 μ l 0.1% formic acid for MS analysis.
Peptides were analyzed in an Orbitrap Fusion Lumos mass spectrometer 63 (Thermo Scientific) coupled to an EASY-nLC (Thermo Scientific) liquid chromatography system, with a 2-μ m, 500-mm EASY-Spray column. The peptides were eluted over a 120-min linear gradient from 96% buffer A (water) to 40% buffer B (acetonitrile), then continued to 98% buffer B over 20 min with a flow rate of 250 nl/min. Each full MS scan (R = 60,000) was followed by 20 data-dependent MS2 (R = 15,000) with high-energy collisional dissociation and an isolation window of 2.0 m/z. The normalized collision energy was set to 35. Precursors of charge states 4-6 were collected for MS2 scans; monoisotopic precursor selection was enabled, and a dynamic exclusion window was set to 30.0 s.
Raw LC-MS/MS data files were converted into mgf format with Proteome Discoverer (Thermo Scientific) and searched with pLink 64,65 with default FDR < 5%, maximum e value set at = 0.001, trypsin digest with up to three missed cleavages, constant modification at 1 = carbamidomethyl [C], and variable modification at 1 = oxidation [M]. The cross-linker was set to BS3 ([K [K 138.068 138.068 156.079 156.079). Mass tolerances for fragments and precursors were left unaltered. mgf files were searched against a database comprising Fasta sequences of Cdc48, Ufd1, and Npl4. Cross-linking/MS data are in Supplementary Dataset 2.
To estimate the dynamic range of the BS3 spacer in solution, we performed an MD simulation of BS3 with YASARA Dynamics (YASARA Biosciences). A target structure in pdb format was generated from the BS3 structural formula. MD simulation was carried out for 25 ns in explicit water with 0.9% NaCl, at 298 K with the AMBER14 force field. The spacer length was recorded as the C4-C11 distance. BS3 MD simulation data are in Supplementary Dataset 3.
Hydrogen/deuterium-exchange mass spectrometry. Five micromolar stock solutions of C. thermophilum Npl4 residues 129-602 or the full-length UN complex were prepared in equilibration buffer (10 mM HEPES, pH 7.5, 100 mM NaCl, and H 2 O). To initiate labeling, 3 μ l of each protein was diluted with 45 μ l labeling buffer (10 mM HEPES, pD 7.5, 100 mM NaCl, and 99.8% D 2 O) and incubated for 10 s, 10 min, 1 h, or 4 h). At the specified time, 48 μ l of quench buffer (150 mM potassium phosphate, pH 2.4, 0 °C) was added. All subsequent steps were performed at 0 °C.
Quenched samples were digested online with an immobilized pepsin column (prepared in house according to ref. 66 ) and directed into a Waters nanoAcquity UPLC with HDX technology 67 . Peptides were trapped on a Waters UPLC BEH C18 1.7-μ m VanGuard BEH column and desalted with 0.1% formic acid in water for 3 min at 100 μ l/min. Peptides were separated over 6 min with a 5-35% gradient of water/acetonitrile with 0.1% formic acid at a flow rate of 100 μ l/min with a Waters HSS T3 1.8-μ m C18 analytical column (1.0 mm × 50 mm). Deuterium incorporation was measured with a Waters Synapt G2Si system equipped with a standard ESI source in HDMS E mode. Mass spectra were acquired over an m/z range of 50-2,000, and mass accuracy was confirmed by calibration with 500 fmol/μ l of human glu-fibrinopeptide. Peptic peptides were identified with ProteinLynx Global Server (PLGS) 3.0 (Waters), and deuterium incorporation was measured with DynamX 3.0 (Waters). The deuterium levels were not corrected for back exchange and are reported as relative 68 . All experiments were performed in duplicate.
Substrate-unfolding assays. mEos3.2 was purified and polyubiquitinated as previously described 17 . Briefly, the protein was expressed as an N-terminal His14-SUMO fusion. After SUMO cleavage, an N-terminal arginine is exposed, thus facilitating ubiquitination by the purified S. cerevisiae enzymes Uba1, Ubc2, and Ubr1. Eos was separated from the ubiquitination machinery on the basis of a C-terminal SBP tag, which was then removed by 3C protease. Finally, substrates bearing ubiquitin chains of 5-10 moieties were isolated by gel filtration. The substrate molecules carry a single ubiquitin chain with K48 linkages at K19 (ref. 17 ).
Substrate unfolding was monitored as previously described 17 . Briefly, the substrate (200 nM) was mixed with 300 nM UN variants and 400 nM Cdc48 variants in 50 mM HEPES, pH 7.2, 100 mM KCl, 10 mM MgCl 2 , and 0.25 mg/ ml protease-free bovine serum albumin. After 10-min incubation at 30 °C, ATP (2 mM) was added, and fluorescence (excitation, 540 nm; emission, 580 nm) was monitored in a Spectramax M5 plate reader for 30 min. Unfolding assay data are in Supplementary Dataset 1.
Substrate binding experiments. The C. thermophilum Npl4 Zn 2+ finger-MPN-CTD fragments (residues 129-602, 129-519, or 519-602) with an N-terminal SBP tag were incubated with streptavidin agarose beads (Pierce) in binding buffer (50 mM Tris, pH 8.0, and 150 mM NaCl) for 30 min at room temperature. The beads were washed three times with binding buffer to remove excess bait protein. Next, DyLight 800-labeled, polyubiquitinated superfolder GFP, generated as described for the Eos substrate above and purified by gel filtration, was incubated with the beads for 30 min at a concentration of 50 nM in 100 μ l binding buffer. The beads were again washed three times. Bound material was eluted with binding buffer plus 1 mM biotin and subjected to SDS-PAGE and fluorescence scanning on an Odyssey CLx infrared scanner (Licor) followed by Coomassie blue staining.
Yeast experiments. The npl4-1 strain (Mat a npl4-1 ura3-52 leu2∆ 1 trp1∆ 63) was transformed with plasmids derived from pPS402 (gift from P. Carvalho, originally generated by the laboratory of P. Silver 69 ). The original plasmid encodes wild-type Npl4 under its endogenous promoter and includes a Ura3 cassette. Initial cultures were grown at room temperature, because the npl4-1 strain grows poorly at 30 °C. Yeast were spotted in tenfold serial dilution on SD -Ura plates and incubated at room temperature, 30 °C, or 37 °C for 2-3 d.
Reporting Summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this article. Data availability. Atomic coordinates and structure factors for zf-Npl4-MPN-CTD have been deposited in the wwPDB under accession code PDB 6CDD. X-ray diffraction data are available from SBGrid under identifier https://doi. org/10.15785/SBGRID/565. Cryo-EM maps have been deposited in the Electron Microscopy Data Bank (EMDB) under accession codes EMD-7476 (Cdc48-Ufd1-Npl4 (ATP-γ S); model in PDB 6CHS), EMD-7477 (Cdc48 (ADP)), EMD-7478 (Cdc48 (ATP-γ S)), and EMD-7479 (Cdc48-Ufd1-Npl4 (ADP)). Source data for Fig. 3a,c, 8a and 10b Corresponding author(s): Thomas Walz, Tom Rapoport Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.
Please do not complete any field with "not applicable" or n/a. Refer to the help text for what text to use if an item is not relevant to your study. For final submission: please carefully check your responses for accuracy; you will not be able to make changes later.
Experimental design 1. Sample size
Describe how sample size was determined.
For cryo-EM, particles were collected and data processed until maps at the given resolutions were obtained. There were no predetermined resolution or particle number cutoffs. For crystallography, a single crystal was sufficient to obtain a dataset for structure solution. For unfolding assays, three technical replicates were considered to be representative of the experimental variation.
Data exclusions
Describe any data exclusions.
For cryo-EM data, images were manually inspected and rejected if considered of inadequate quality for further image processing (e.g., ice contamination, blurriness, bad CTF fit, etc.) During refinement, 2D and 3D classes showing poor averages were removed as described in Methods.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
All attempts at replication were successful.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
The experiments in this study did not require randomization, as there were no groups subjected to differing treatments.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
The experiments in this study did not require blinding to group allocation, as there were no groups subjected to differing treatments. Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
nature research | life sciences reporting summary
November 2017
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed). n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section. b. Describe the method of cell line authentication used. The strain was validated by complementation of the temperature sensitive phenotype with a plasmid encoding wild-type Npl4. c. Report whether the cell lines were tested for mycoplasma contamination.
The strain was not tested for mycoplasma contamination.
d. If any of the cell lines used are listed in the database of commonly misidentified cell lines maintained by ICLAC, provide a scientific rationale for their use.
No commonly misidentified cell lines were used.
Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
Description of research animals
Provide all relevant details on animals and/or animal-derived materials used in the study.
No animals were used.
Policy information about studies involving human research participants
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
The study did not involve human research participants.
